3M Company Common Stock (MMM)
Stock · NYSE · Health Care
$164.68as of 10/16/2026
Price chart
Active signals
MMM Signal Track Record
How signals performed across all stocks →What MMM's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 37 | -0.1% | 49% | July 21, 2026 |
| Bollinger Band Breakout | 26 | +0.9% | 62% | July 21, 2026 |
| Bollinger Band Breakdown | 21 | +1.7% | 52% | August 28, 2026 |
| 200-Day Moving Average TouchActive now | 10 | -1.2% | 50% | October 9, 2026 |
| Any 20-session window (baseline) | +1.2% | 58% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About MMM
3M Company provides diversified technology services in the America, the Asia Pacific, Europe, the Middle East, Africa, and internationally. It operates through three segments: Safety and Industrial, Transportation and Electronics, and Consumer. The Safety and Industrial segment provides industrial abrasives and finishing for metalworking applications; autobody repair solutions; industrial specialty products, such as…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 60,500
- Website
- www.3m.com/
Fundamentals
- 1-day range
- $164.64$167
- Market cap
- $93.20B
- P/E (trailing)
- 28.58
- P/E (forward)
- 16.84
- EPS (trailing)
- $5.63
- Dividend yield
- 6.25%
- Beta
- 1.01
- Avg. volume
- 3.14M
- Ex-dividend date
- August 24, 2026
- Dividend pay date
- September 11, 2026
How 3M Company Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 3, 2026 · via SEC EDGAR / Finnhub
Forecasts
18 analyst ratings
3M Company Common Stock Competitors
Chosen by industry and closest market cap.
- MMM3M Company Common Stock$164.75▼ 0.35%Market cap $93.20BP/E 28.58$139.34$184.9
- BSXBoston Scientific Corporation Common Stock$44.39▲ 0.57%Market cap $71.45BP/E 17.32$41.39$105.65
- SYKStryker Corporation Common Stock$294.66▲ 0.49%Market cap $129.43BP/E 29.93$267$392.55
- BDXBecton Dickinson and Company Common Stock$191.75▼ 1.04%Market cap $48.79BP/E 54.13$127.59$193.07
- MDLNMedline Inc. Class A Common Stock$35.96▼ 1.67%Market cap $45.34BP/E 69.38$31.49$50.88
- RMDResMed Inc. Common Stock$238.97▼ 1.35%Market cap $32.38BP/E 22.23$180.27$277.67
- DXCMDexCom Inc. Common Stock$86.04▼ 1.90%Market cap $31.33BP/E 32.73$54.11$92.59
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| MMM 3M Company Common Stock | $93.20B | 28.58 | $164.75 | ▼ 0.35% | $139.34$184.9 |
| BSX Boston Scientific Corporation Common Stock | $71.45B | 17.32 | $44.39 | ▲ 0.57% | $41.39$105.65 |
| SYK Stryker Corporation Common Stock | $129.43B | 29.93 | $294.66 | ▲ 0.49% | $267$392.55 |
| BDX Becton Dickinson and Company Common Stock | $48.79B | 54.13 | $191.75 | ▼ 1.04% | $127.59$193.07 |
| MDLN Medline Inc. Class A Common Stock | $45.34B | 69.38 | $35.96 | ▼ 1.67% | $31.49$50.88 |
| RMD ResMed Inc. Common Stock | $32.38B | 22.23 | $238.97 | ▼ 1.35% | $180.27$277.67 |
| DXCM DexCom Inc. Common Stock | $31.33B | 32.73 | $86.04 | ▼ 1.90% | $54.11$92.59 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 3M Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Callbenzinga · 10/14/2026
- 3M (MMM) Stock Could Be A Bargain On Future Cash FlowYahoo · 10/10/2026
- Friday's session: top gainers and losers in the dow jones indexChartMill · 10/9/2026
- Top dow jones movers in Friday's sessionChartMill · 10/9/2026
- JP Morgan Maintains Overweight on 3M, Lowers Price Target to $185Benzinga · 10/9/2026
- Carlisle Exhibits Strong Prospects Despite Persisting HeadwindsYahoo · 10/9/2026
- Will MMM's Safety & Industrial Segment Remain a Core Strength in 2026?Yahoo · 10/8/2026
- Which dow jones stocks are moving on Wednesday?ChartMill · 10/7/2026
- Is 3M (MMM) Undervalued As Product Momentum And Its 2026 Outlook Build?Yahoo · 10/7/2026
Insider Activity
Insider Actions →- Kshirsagar Tushar A. · October 7, 2026 · Option Exercise53 @ $162.12
- Kshirsagar Tushar A. · October 7, 2026 · Tax Withholding53 @ $162.12
- Christian T. Goralski Jr. · October 7, 2026 · Option Exercise217 @ $162.12
- Christian T. Goralski Jr. · October 7, 2026 · Option Exercise219 @ $162.12
- Christian T. Goralski Jr. · October 7, 2026 · Option Exercise1.3K @ $162.12
- Christian T. Goralski Jr. · October 7, 2026 · Tax Withholding1.7K @ $162.12
- Kevin H. Rhodes · October 7, 2026 · Option Exercise176 @ $162.12
- Kevin H. Rhodes · October 7, 2026 · Tax Withholding176 @ $162.12
- Maheshwari Anurag · October 1, 2026 · Option Exercise10.9K @ $163.02
- Maheshwari Anurag · October 1, 2026 · Tax Withholding5.0K @ $163.02
- Cunningham Jennifer A. · September 1, 2026 · Grant7.0K
- George Bobby K · September 1, 2026 · Grant15.9K
- Rodriguez Beatriz Karina Chavez · August 5, 2026 · Sale3.6K @ $182.51
- Theresa E. Reinseth · July 23, 2026 · Sale924 @ $169.42
- John Patrick Banovetz · July 23, 2026 · Option Exercise7.9K @ $154.69
Institutional Ownership
March 31, 2026
- Total shares held
- 329.97M
- Total value held
- $46.65B
- Institutional holders
- 2110
- Unknown42.66M
- Unknown34.23M
- Unknown27.72M
- Unknown11.90M
- Unknown9.48M
- Unknown9.17M
- Unknown7.93M
- Unknown7.48M
- Unknown5.63M
- Unknown5.59M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
3M to challenge $1.4B Australian PFAS lawsuit ahead of Q3 earnings
3M is preparing to challenge Australia's $1.4 billion PFAS contamination lawsuit, a major legal development for the company. At the same time, market participants are looking ahead to 3M's upcoming third-quarter earnings, with Wall Street projections offering insights into key metrics. The stock is currently trading within its 52-week range, with an average analyst target of $186.15.
3M to challenge $1.4B Australian PFAS lawsuit ahead of Q3 earnings. 3M is preparing to challenge Australia's $1.4 billion PFAS contamination lawsuit, a major legal development for the company. At the same time, market participants are looking ahead to 3M's upcoming third-quarter earnings, with Wall Street projections offering insights into key metrics. The stock is currently trading within its 52-week range, with an average analyst target of $186.15.